Company page

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker ELTX. The company focuses on developing innovative therapies for cancer treatment. With a market capitalization of approximately $70.4 million, Elicio Therapeutics is positioned within the growing biotech sector.